Results 231 to 240 of about 69,036 (281)

The Topographical, Sensory, and Temporal Characteristics of Pain in Parkinson’s Disease: A Cross‐Sectional Survey

Pain Practice, Volume 26, Issue 4, April 2026.
ABSTRACT Background Pain in Parkinson's disease (PD) manifests clinically in a variety of ways and several pain types have been identified, however, their characteristics have not been extensively studied. Objective To describe the characteristics of common pain types in people with PD.
Anthony Mezzini, Saravana Kumar, Sue Sharrad, Joanne Harmon, Marion Eckert   +4 more
wiley   +1 more source

AI-Driven Analysis of Wrist-Worn Sensor Data for Monitoring Individual Treatment Response and Optimizing Levodopa Dosing in Parkinson's Disease. [PDF]

Sensors (Basel)
Sander M, Messner MR, Knapp SK, Pfister FMJ, Fietzek UM.   +4 more
europepmc   +1 more source

Accelerated Progression of Gait Impairment in Parkinson's Disease and REM Sleep Without Atonia

Annals of Clinical and Translational Neurology, Volume 13, Issue 3, Page 517-529, March 2026.
ABSTRACT Objective People with Parkinson's disease (PD) and rapid eye movement (REM) sleep without atonia (RSWA) often have more severe gait disturbances compared to PD without RSWA. The association between the presence and expression of RSWA and the rate of progression of gait impairment in PD is unknown.
Sommer L. Amundsen‐Huffmaster, Jae Woo Chung, Maria E. Linn‐Evans, Matthew N. Petrucci, Chiahao Lu, Destiny J. Weaver, Joshua De Kam, Scott E. Cooper, Paul J. Tuite, Aleksandar Videnovic, Michael J. Howell, Colum D. MacKinnon   +11 more
wiley   +1 more source

Echoes of Childhood Trauma: A Rare Case of Holmes Tremor With Neuroanatomic Imaging and Video Evidence. [PDF]

Cureus
Prasad R, Gazallo D, Coni RJ.
europepmc   +1 more source

Wake‐promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Neuromodulatory subcortical systems (NSS) regulate arousal, cognition, and sleep–wake transitions through widespread influence on cortical and subcortical networks. Increasing evidence links dysfunction of these systems to the pathogenesis of Alzheimer's disease (AD). Degeneration and dysregulation of NSS occurs during the preclinical phase of
Taylor J. Pedersen, Sabrina G. Clemens, Joseph R. Winer, Ashish Sharma, Neus Falgàs, Brendan P. Lucey, Brian A. Gordon, Erik S. Musiek   +7 more
wiley   +1 more source

Consensus expert recommendations for referral of Parkinson's disease patients for deep brain stimulation surgery. [PDF]

NPJ Parkinsons Dis
Safarpour D, Spindler M, Turner TH, Patel N, Vaou O, Cabrera LY, Tolleson C, Tipton PW, Aquino C, Herrington TM, Sidiropoulos C, Hantke N, Lotia M, Miocinovic S, Sharma VD, Mills KA, Wyman-Chick K, Kilbane C, Luca C, Almeida L, Rosenow J, Ooi HY, Mari Z, Luo L, Munhoz RP, Jesus S, Sarva H, Arena M, Revuelta G, Chou KL, Fasano A, Siddiqui MS, Jimenez-Shahed J, Functional Neurosurgical working group of the Parkinson Study Group.   +33 more
europepmc   +1 more source

Neuroprotective and Renoprotective Potential of a Hydroethanolic Extract From the Aerial Parts of Mattiastrum paphlagonicum Bornm. (Boraginaceae)

Chemistry &Biodiversity, Volume 23, Issue 3, March 2026.
ABSTRACT This study provides an analysis of the endemic plant Mattiastrum paphlagonicum Bornm.(Synonym Paracaryum paphlagonicum (Bornm.) R.R. Mill), focusing on enzyme activity, secondary metabolite content, antioxidant capacity (DPPH, ABTS, and FRAP), as well as phenolic and flavonoid levels, all within the context of a hydroethanolic extract prepared
Ayşenur Kayabaş Avşar, Eda Büker, Ertan Yildirim, Dorina Casoni, Simona Codruta Aurora Cobzac   +4 more
wiley   +1 more source

Focal dystonia attributed to secondary Nigrostriatal pathway disruption following brainstem Hemorrhage: a case report. [PDF]

Oxf Med Case Reports
Zhou L, Zhao C, Sun Z, Man X, Xiang Y.
europepmc   +1 more source

Three-Dimensional Screen Printing Technology Enables Sequential Release of Carbidopa and Levodopa-A New Approach Improving Levodopa Delivery for Treating Parkinson's Disease. [PDF]

Pharmaceutics
Enke M, Bünger M, Aedtner E, Kastner S, Gruschwitz F, Kühne K, Czernik-Schulz D, Greeley DR, Volc D, Buzachnich-Ladinig A, Schneeberger A.   +10 more
europepmc   +1 more source

Faith, fasting, and well-being: Emirates Neurology Society consensus guidelines on safe Ramadan fasting in Parkinson's disease. [PDF]

Front Neurol
Mittal SO, Krystkowiak P, Ramberg CJ, Sarathchandran P, Hassan A, Iantorno V, Cirasanambati M, Al Aloma M, Maiti T, Al Rukn S.   +9 more
europepmc   +1 more source